Freenome, Inc. <FRNM.O>: BTIG initiates coverage with buy rating; price target $17
FRNM•Related News
Canada stocks-Toronto futures little changed as investors await domestic inflation data
EWC•
Adial Pharmaceuticals posts bigger-than-expected Q2 net loss, hurt by acquisition charges
ADIL•
Can-Fite plans Phase IIb trial of namodenoson plus gemcitabine in advanced pancreatic cancer
CANF•
EyePoint eye drug misses main goal in late-stage trial
EYPT•
AmpliTech targets positive EBITDA in fiscal 2027 as it scales higher-margin Open RAN radio orders
AMPG•